全文获取类型
收费全文 | 1857篇 |
免费 | 248篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 78篇 |
妇产科学 | 49篇 |
基础医学 | 206篇 |
口腔科学 | 17篇 |
临床医学 | 190篇 |
内科学 | 438篇 |
皮肤病学 | 27篇 |
神经病学 | 136篇 |
特种医学 | 186篇 |
外科学 | 175篇 |
综合类 | 71篇 |
一般理论 | 3篇 |
预防医学 | 283篇 |
眼科学 | 21篇 |
药学 | 144篇 |
中国医学 | 6篇 |
肿瘤学 | 77篇 |
出版年
2023年 | 10篇 |
2021年 | 27篇 |
2020年 | 12篇 |
2019年 | 19篇 |
2018年 | 25篇 |
2017年 | 20篇 |
2016年 | 40篇 |
2015年 | 66篇 |
2014年 | 39篇 |
2013年 | 60篇 |
2012年 | 66篇 |
2011年 | 77篇 |
2010年 | 68篇 |
2009年 | 59篇 |
2008年 | 102篇 |
2007年 | 84篇 |
2006年 | 82篇 |
2005年 | 95篇 |
2004年 | 83篇 |
2003年 | 49篇 |
2002年 | 90篇 |
2001年 | 66篇 |
2000年 | 52篇 |
1999年 | 49篇 |
1998年 | 37篇 |
1997年 | 47篇 |
1996年 | 46篇 |
1995年 | 41篇 |
1994年 | 36篇 |
1993年 | 39篇 |
1992年 | 37篇 |
1991年 | 34篇 |
1990年 | 40篇 |
1989年 | 56篇 |
1988年 | 43篇 |
1987年 | 31篇 |
1986年 | 29篇 |
1985年 | 27篇 |
1984年 | 25篇 |
1983年 | 22篇 |
1982年 | 16篇 |
1981年 | 16篇 |
1980年 | 17篇 |
1979年 | 18篇 |
1978年 | 10篇 |
1976年 | 17篇 |
1974年 | 8篇 |
1971年 | 8篇 |
1970年 | 14篇 |
1968年 | 14篇 |
排序方式: 共有2117条查询结果,搜索用时 437 毫秒
51.
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort 总被引:2,自引:0,他引:2
Urowitz MB Gladman D Ibañez D Fortin P Sanchez-Guerrero J Bae S Clarke A Bernatsky S Gordon C Hanly J Wallace D Isenberg D Ginzler E Merrill J Alarcón GS Steinsson K Petri M Dooley MA Bruce I Manzi S Khamashta M Ramsey-Goldman R Zoma A Sturfelt G Nived O Maddison P Font J van Vollenhoven R Aranow C Kalunian K Stoll T;Systemic Lupus International Collaborating Clinics 《Arthritis and rheumatism》2008,59(2):176-180
OBJECTIVE: To examine the accumulation of risk factors over 3 years in a multicenter, international inception cohort of patients with systemic lupus erythematosus (SLE). METHODS: The Systemic Lupus International Collaborating Clinics registry for atherosclerosis comprises 27 centers from 11 countries. An inception cohort of 935 patients with SLE was assembled, according to a standardized protocol, from 2000 to 2006 to study risk factors for atherosclerosis. Both classic and other coronary artery disease (CAD) risk factors were collected at entry and through 3 years of followup. Therapy was documented over the 3 years. The Framingham 10-year risk factor profile was calculated for each patient at year 1 and year 3. RESULTS: A total of 278 patients from the inception cohort were followed for 3 years and constituted the population for this study. At enrollment a substantial number of patients already demonstrated several risk factors for CAD, both classic and other. All risk factors increased from enrollment over the 3 years of followup. Treatment of hypertension and hypercholesterolemia also increased over 3 years, but less so for hypercholesterolemia. The Framingham 10-year CAD risk profile was higher in men than in women both at entry and at 3 years, and remained unchanged over the 3 years. Corticosteroid use increased only slightly over 3 years, but use of antimalarials and immunosuppressive agents increased to a greater extent. CONCLUSION: Patients with SLE should be monitored for CAD risk factors from the time of diagnosis and appropriate treatment should be instituted early. 相似文献
52.
53.
A monokine regulates colony-stimulating activity production by vascular endothelial cells 总被引:20,自引:0,他引:20
Human umbilical vein endothelial cells were cultured in supernatants of peripheral blood monocytes that had been cultured for 3 days with and without lactoferrin. Colony-stimulating activity (CSA) was measured in supernatants of the endothelial cell cultures and appropriate control cultures using normal, T-lymphocyte-depleted, phagocyte-depleted, low- density bone marrow cells in colony growth (CFU-GM) assays. Monocyte- conditioned medium contained a nondialyzable, heat labile factor that enhanced 4-15--fold the production of CSA by endothelial cells. The addition of lactoferrin to monocyte cultures reduced the activity of this monokine by 69%. Lactoferrin did not inhibit CSA production by monokine-stimulated endothelial cells. Therefore, vascular endothelial cells are potent sources of CSA, the production of CSA by these cells is regulated by a stimulatory monokine, and the production and/or release of the monokine is inhibited by lactoferrin, a neutrophil- derived putative feedback inhibitor of granulopoiesis. Inasmuch as a similar monokine is known to stimulate CSA production by fibroblasts and T lymphocytes, we suggest that mononuclear phagocytes play a pivotal role in the regulation of granulopoiesis by recruiting a variety of cell types to produce CSA. 相似文献
54.
再发骨质疏松性椎体压缩骨折保守治疗患者出院后生存质量 总被引:1,自引:0,他引:1
目的:对比初次和再发骨质疏松性椎体压缩骨折(osteoporotic vertebral compression fractures,OVCFs)患者保
守治疗的生存质量,了解再次骨折对此类患者生存质量各方面的影响。方法:回顾性观察治疗OVCFs后出现再骨折
的患者30名(再骨折组)和同时期行保守治疗OVCFs后未发生再骨折的基本条件相似的患者30例(对照组),比较两组出
院后3个月时SF-36简明健康健康状况调查表的调查结果。结果:再骨折组治疗后的8个维度均不同程度较对照组变差
(均P<0.01)。结论:再骨折组患者的生存质量明显低于对照组,并且会进一步影响患者的心理预期、情绪和社会活动
的各个方面。 相似文献
55.
56.
J. S. Dooley A. Gooding J. M. T. Hamilton-Miller W. Brumfitt S. Sherlock 《Liver international》1983,3(4):201-206
ABSTRACT— The biliary excretion and pharmacokinetics of mezlocillin have been studied in jaundiced patients with total external bile drainage through a percutaneous transhepatic catheter. In 10 of 11 studies, 2 g mezlocillin intravenously resulted in biliary concentrations sufficient to exceed the minimum inhibitory concentrations of most common biliary pathogenic organisms. In 6 h, 0.2–6.2% of the dose given was recovered in bile. The biliary clearance was 0.21–7.82 ml/min and increased with the duration of biliary decompression. The serum half-life of mezlocillin was prolonged (1.81 ± 0.23 h, mean ± SD), and was due to reduced biliary and renal clearance. 相似文献
57.
Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. 总被引:4,自引:0,他引:4
Hong-Lei Weng Bao-En Wang Ji-Dong Jia Wan-Fen Wu Jian-Zhong Xian Peter R Mertens Wei-Min Cai Steven Dooley 《Clinical gastroenterology and hepatology》2005,3(8):819-828
BACKGROUND & AIMS: Hepatic fibrosis due to chronic HBV infection has enormous socioeconomic impact. Besides strategies targeting virus elimination, prevention or reversal of liver fibrosis is amenable. Given the antifibrotic activity of interferon-gamma (IFN-gamma), a randomized open-labeled multicenter trial was initiated to test IFN-gamma in HBV infection. METHODS: HBsAg-positive patients with biopsy proven hepatic fibrosis (n = 99, stages 2-4, Scheuer criterion) were treated with diammone-glycyrrhizinate and potassium-magnesium aspartate. Sixty-six randomly assigned patients were treated with 50 mug IFN-gamma intramuscularly on a daily basis for 3 months and on alternate days the subsequent 6 months. Efficacy was evaluated by liver biopsy and serologic markers. RESULTS: Fifty-four patients in the IFN-gamma group and 29 patients in the control group completed the study. The hepatic fibrosis score was significantly reduced in 63% of IFN-gamma treated patients compared with 24.1% in the control group by using a semiquantitative scoring system evaluating both liver architecture and fibrotic deposits. Mean values for the total fibrosis score decreased from 13.8 +/- 5.8 to 10.1 +/- 5.1 in the IFN-gamma group (P = .0001), whereas they were unchanged in control subjects (13.2 +/- 6.8 vs 12.6 +/- 4.8, P = .937). The Scheuer system showed 12 out of 54 patients improved >or=1 stage(s) in the IFN-gamma group compared with 1 of 29 in the control group. Antifibrotic activity might be attributed to decreased transforming growth factor-beta signaling via phosphorylated Smad2 and reduced number of activated, alpha-smooth muscle actin positive hepatic stellate cells. CONCLUSIONS: IFN-gamma treatment for 9 months improves fibrosis scores in patients with chronic HBV infection most likely by antagonizing profibrogenic transforming growth factor-beta effects. 相似文献
58.
N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus 总被引:1,自引:0,他引:1
Cooper GS Treadwell EL Dooley MA St Clair EW Gilkeson GS Taylor JA 《The Journal of rheumatology》2004,31(1):76-80
OBJECTIVE: To examine the association between N-acetyl transferase (NAT) genotype (NAT1 and NAT2) and risk of developing systemic lupus erythematosus (SLE). METHODS: DNA samples were collected from 243 recently diagnosed cases and 298 controls enrolled in a population based case-control study conducted in 60 counties in North Carolina and South Carolina, USA. RESULTS: There was no association between SLE and NAT1 genotype (OR 0.96, 95% CI 0.65, 1.4 for the presence of a *10 allele) or NAT2 genotype (OR 1.1, 95% CI 0.73, 1.6 for the slow- compared with fast-acetylation genotype). We saw some evidence of interaction between NAT genotypes and use of hair dyes (a source of arylamines), with higher risk seen among hair dye users who had both the *10 NAT1 allele and the NAT2 slow-acetylation genotype (OR 2.9, 95% CI 1.2, 6.9 in this subgroup compared with all others). CONCLUSION: Our results suggest that although there is little overall association between NAT genotypes and risk of developing SLE, the interaction between NAT1 and NAT2 and specific exposures such as hair dyes may be important. This finding highlights the need to consider exposure when assessing genetic susceptibility. 相似文献
59.
Lourdes Serrano Paloma Martínez-Redondo Anna Marazuela-Duque Berta N. Vazquez Scott J. Dooley Philipp Voigt David B. Beck Noriko Kane-Goldsmith Qiang Tong Rosa M. Rabanal Dolors Fondevila Purificación Mu?oz Marcus Krüger Jay A. Tischfield Alejandro Vaquero 《Genes & development》2013,27(6):639-653
The establishment of the epigenetic mark H4K20me1 (monomethylation of H4K20) by PR-Set7 during G2/M directly impacts S-phase progression and genome stability. However, the mechanisms involved in the regulation of this event are not well understood. Here we show that SirT2 regulates H4K20me1 deposition through the deacetylation of H4K16Ac (acetylation of H4K16) and determines the levels of H4K20me2/3 throughout the cell cycle. SirT2 binds and deacetylates PR-Set7 at K90, modulating its chromatin localization. Consistently, SirT2 depletion significantly reduces PR-Set7 chromatin levels, alters the size and number of PR-Set7 foci, and decreases the overall mitotic deposition of H4K20me1. Upon stress, the interaction between SirT2 and PR-Set7 increases along with the H4K20me1 levels, suggesting a novel mitotic checkpoint mechanism. SirT2 loss in mice induces significant defects associated with defective H4K20me1–3 levels. Accordingly, SirT2-deficient animals exhibit genomic instability and chromosomal aberrations and are prone to tumorigenesis. Our studies suggest that the dynamic cross-talk between the environment and the genome during mitosis determines the fate of the subsequent cell cycle. 相似文献
60.
KA Hodgkinson SP Connors N Merner A Haywood T‐L Young WJ McKenna B Gallagher F Curtis AS Bassett PS Parfrey 《Clinical genetics》2013,83(4):321-331
To determine the phenotype and natural history of a founder genetic subtype of autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) caused by a p.S358L mutation in TMEM43. The age of onset of cardiac symptoms, clinical events and test abnormalities were studied in 412 subjects (258 affected and 154 unaffected), all of which occurred in affected males significantly earlier and more often than unaffected males. Affected males were hospitalized four times more often than affected females (p ≤ 0.0001) and died younger (p ≤ 0.001). The temporal sequence from symptoms onset to death was prolonged in affected females by 1–2 decades. The most prevalent electrocardiogram (ECG) manifestation was poor R wave progression (PRWP), with affected males twice as likely to develop PRWP as affected females (p ≤ 0.05). Left ventricular enlargement (LVE) occurred in 43% of affected subjects, with 11% fulfilling criteria for dilated cardiomyopathy. Ventricular ectopy on Holter monitor was common and occurred early: the most diagnostically useful clinical test. No symptom or test could rule out diagnosis. This ARVC subtype is a sex‐influenced lethal arrhythmogenic cardiomyopathy, with a unique ECG finding, LV dilatation, heart failure and early death, where molecular pre‐symptomatic diagnosis has the greatest clinical utility. 相似文献